论文部分内容阅读
膀胱癌为泌尿系统常见肿瘤,其中绝大多数是移行上皮癌,且多为浅表损害性膀胱癌,多数术后一年内复发。本文在体内外初步研究了LAK 细胞对膀胱癌细胞的杀伤活性和疗效观察,报告如下。材料与方法一、临床资料。1991年我院膀胱癌住院手术病人10例,均经病理证实为移行上皮细胞癌。其中男9例,女1例,平均年龄59.5岁。T_1期6例,T_2期3例,T_3期1例,均行TuR 局部或部分切除,其中1例T_2期病人于5年内复发
Bladder cancer is a common urological tumor, the vast majority of which are transitional epithelial cancer, mostly superficial lesions of the bladder, most relapse within a year after surgery. This article in vitro and in vivo studies of LAK cells on the cytotoxicity of bladder cancer cells and the efficacy of the report are as follows. Materials and methods First, the clinical data. In 1991, 10 cases of hospitalized patients with bladder cancer in our hospital were pathologically confirmed as transitional cell carcinoma. There were 9 males and 1 females, with an average age of 59.5 years. T_1 6 cases, T_2 3 cases, T_3 1 cases, were performed TuR partial or partial removal, of which 1 case of T 2 patients relapse within 5 years